Peter Palmer

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

C H Weaver, B Hazelton, Robert Birch et al. · Blood · 1995 · 621 citations · Full text

Medicine, Cell Biology, Hematology +17

Phase III Double-Blind Placebo-Controlled Study of Farnesyl Transferase Inhibitor R115777 in Patients With Refractory Advanced Colorectal Cancer

Sheela Rao, David Cunningham, Armand de Gramont et al. · Journal of Clinical Oncology · 2004 · 239 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II Study of the Efficacy and Tolerability of Two Dosing Regimens of the Farnesyl Transferase Inhibitor, R115777, in Advanced Breast Cancer

Stephen R.D. Johnston, Tamas Hickish, Stephen Houston et al. · Journal of Clinical Oncology · 2003 · 196 citations

Medicine, Oncology, Pharmacology +16

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Peter Palmer, J. Vinke, Thierry Philip et al. · Annals of Oncology · 1992 · 156 citations · Full text

Medicine, Immunology, Oncology +14

Phase I Clinical and Pharmacologic Study of Chronic Oral Administration of the Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer

Mirjam Crul, G.J.M. de Klerk, M. Swart et al. · Journal of Clinical Oncology · 2002 · 130 citations

Medicine, Oncology, Pharmacology +15